Evidence map›Paper›PMID 28652404›Full record

ReviewThe Journal of biological chemistry2017

Current prospects of type II interferon γ signaling and autoimmunity.

Daniel S Green, Howard A Young, Julio C Valencia

Open access · hybridAbstract readReview
In one paragraph

Review in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 175 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. IFNγ in human sepsis: a scoping review.Annals of intensive care · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Impact of Methylated Cyclodextrin KLEPTOSEInternational journal of molecular sciences · 2024
    Article
  18. Article
  19. Development of a highly sensitive platform for protein-protein interaction detection and regulation of T cell function.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Daniel S GreenFrom the Women's Malignancy Branch, Translational Genomics Section, Center for Cancer, NCI, National Institutes of Health, Bethesda, Maryland 20892.
Howard A YoungCancer and Inflammation Program, Center for Cancer Research, NCI-Frederick, National Institutes of Health, Frederick, Maryland 21702-1201. Electronic address: Younghow@nih.gov.
Julio C ValenciaCancer and Inflammation Program, Center for Cancer Research, NCI-Frederick, National Institutes of Health, Frederick, Maryland 21702-1201. Electronic address: valencij@mail.nih.gov.
Center for Cancer Research · USFrederick National Laboratory for Cancer Research · USNational Institutes of Health · US

Funding

Control of Cytokine Gene Expression in LymphoidMyeloid CellsZIABC009283 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI YOUNG, HOWARD · 2009 to 2024
$22.7M
6 · The paper itself

Abstract

Interferon γ (IFNγ) is a pleiotropic protein secreted by immune cells. IFNγ signals through the IFNγ receptor, a protein complex that mediates downstream signaling events. Studies into IFNγ signaling have provided insight into the general concepts of receptor signaling, receptor internalization, regulation of distinct signaling pathways, and transcriptional regulation. Although IFNγ is the central mediator of the adaptive immune response to pathogens, it has been shown to be involved in several non-infectious physiological processes. This review will provide an introduction into IFNγ signaling biology and the functional roles of IFNγ in the autoimmune response.

Indexed as

AutoimmunityModels, BiologicalSignal TransductionAnimalsAntigen-Presenting CellsAutophagosomesCaveolaeClathrin-Coated VesiclesDimerizationEndocytosisHumansInterferon-gammaInterferon gamma ReceptorMacrophagesMembrane MicrodomainsProtein MultimerizationIFNG protein, humanIFNGR2 protein, humanInterferon-gammaInterferon gamma ReceptorReceptors, Interferonautoimmune diseaseautoimmunityinterferonsignalingsignal transducers and activators of transcription 1 (STAT1)

Identifiers

PMID28652404
PMCPMC5572907
OpenAlexW2731035140

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.